News
A unique feature of HR is that it repairs the damage to the DNA in a highly accurate way. In eukaryotic cells (those with a ...
The poster presentations will be available on Connect’s website under the Presentations and Publications section.
The US Food and Drug Administration (FDA) has approved dupilumab for the treatment of chronic spontaneous urticaria (CSU) in patients aged 12 years and older who “remain symptomatic despite H1 ...
The success of dupilumab, marketed by Sanofi under the name Dupixent, is evident in its remarkable $13 billion global sales achievement in 2024, marking a significant milestone for the company.
Scientists have found a way to more than double the uptake ability of a chemical structure that can be used for scrubbing carbon dioxide from factory flues. Oregon State University scientists have ...
The mystery byproduct was first noticed in the 1980s and became the subject of EPA-funded research, but scientists were unable to isolate it and determine its molecular formula or structure.
The U-M team suspected that certain fentalogs could potentially be used as antidotes to fentanyl, much in the way that naloxone, which has a chemical structure very close to morphine, is an ...
TARRYTOWN, N.Y. and PARIS, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi will present positive data from the Phase 3 LIBERTY-CUPID Study C evaluating the ...
The researchers report that mean symptom domain scores were 59.3 for dupilumab versus 58.6 for placebo, mean activity scores were 66.3 versus 65.8, and mean impact domain scores were 38.2 versus 37.3.
Dupixent (dupilumab) late-breaking phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine. May 21, 2023. Accessed September 26, 2024.
Similarly, biologics such as the anti-IL-4/IL-13 antibody dupilumab are now available for the treatment ... For NCI-DTP compounds, chemical structures were imported into Maestro (Schrödinger) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results